Life Sciences Archives - Page 18 of 22 - Becker's Hospital Review

Merck sues CMS over drug price negotiations | What's in GV's portfolio? | Mark Cuban to sell Humira biosimilar | Pa. system pulls out of US News ranking | Trinity Life Sciences taps new CEO

June 7, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Merck sues feds to stop Medicare drug price negotiations Full story 2. 'Misguided methodology': Pennsylvania health system withdraws from US News rankings Full story 3. What's in GV's portfolio? 143 healthcare…

Oncologists ration cancer drugs amid shortage | J&J taps Ceramedix for new resident co. | PTC Therapeutics to lay off 94 | Amazon eyes medical affairs lead | Ascension posts $1.4B operating loss

May 31, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Some oncologists are rationing cancer drugs as shortages grow Full story 2. Ascension posts $1.4B Q1 operating loss Full story 3. PTC Therapeutics to lay off 94 Full story 4. The right hybrid…

Athenex to close July 1 | Walgreens 'full steam ahead' on clinical trials | California hospital to file for bankruptcy | Moderna buys Mass. biomanufacturing plant | Healthcare's highest-paid CEOs

May 24, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Athenex to close July 1 Full story 2. California hospital to file for bankruptcy Full story 3. Walgreens remains focused on clinical trials despite CVS exit Full story 4. The right hybrid work…

CVS to shutter clinical trials business | FTC sues to block $28M Amgen-Horizon deal | Syneos Health to be acquired for $7.1B | Eli Lilly must pay $183M+ for violating False Claims Act | The healthiest county in each state

May 17, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. FTC sues to block $28M Amgen-Horizon deal Full story 2. Minnesota drafts compromise to exempt Mayo Clinic from staffing bill Full story 3. CVS to close clinical trials business Full story 4. Legacy…

FDA finds deficiencies at Eli Lilly plant | 1st RSV vaccine gains approval | Novavax to cut 25% of workforce | 5 gene therapy candidates to watch | Penn Med physicians vote to unionize

May 10, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. FDA inspection of Eli Lilly facility finds deficiencies Full story 2. Penn Medicine physicians vote to unionize Full story 3. Novavax to lay off 25% of workforce Full story 4. It's simple: Nurses…

Cepheid to lay off 600+ | Who's paying for gene therapies? | HHS to end COVID-19 vaccine rule | Biopharma investors target oncology, immunology | Police shoot woman in Ga. ER

May 3, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Biotech company Cepheid to lay off 600+ Full story 2. HHS to drop COVID-19 vaccine rule for hospitals Full story 3. Who's paying for gene therapies? Mayo Clinic's Dr. Eric Tichy…

Cedars-Sinai could secure millions from $10.8B biotech deal | Mark Cuban hasn't 'f—ed up' the pharma industry yet | Eli Lilly starts new Mounjaro clinical trial | 13 execs resign | Moderna, IBM explore AI's healthcare potential

April 26, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Cedars-Sinai could collect $800M after $10.8B biotech deal closes Full story 2. California hospital board eliminates interim CEO's job at his suggestion Full story 3. Mark Cuban hasn't 'f—ed up' the…

Emerald Cloud Labs cuts jobs, shuts down offices | mRNA shot sparks 'big shift' in cancer vaccine development | Exec pay at Tenet, HCA, CHS | Horizon Therapeutics made $3B in '22, hasn't licensed a drug in 15 years

April 19, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Emerald Cloud Labs cuts jobs, shuts down San Francisco offices Full story 2. Executive pay at Tenet, HCA and CHS: 5 things to know Full story 3. 'A big shift' in…

Cleveland Clinic, University Hospitals take over biotech co. incubator | Why California can't walk away from Walgreens | Mark Cuban's pharmacy picks up J&J brand-name drug | 35 billionaires in US healthcare

April 12, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Cleveland Clinic, University Hospitals take over biotech company incubator Full story 2. 35 billionaires in US healthcare Full story 3. California can't be 'done' with Walgreens, experts say Full story 4. The number…

Cancer drug trial halted after 2 deaths | J&J scraps RSV vaccine plans | 14 drug shortages worsen amid Akorn closure | New COVID variant in 18 states | 10 healthiest, unhealthiest cities

April 5, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. FDA stops cancer drug trial after 2 patient deaths Full story 2. Coronavirus variant XBB.1.16 spotted in 18 US states Full story 3. 5 weeks later, Akorn's closure racks up 14…